Novo Nordisk names new CEO amid share price slump and concerns over Wegovy, Ozempic sales
Mr Doustdar's appointment came on Tuesday after the abrupt removal in May of his predecessor Lars Fruergaard Jorgensen by Novo and the Novo Nordisk Foundation — the company's controlling shareholder.
The new CEO joined Novo in 1992 and currently serves as vice-president for international operations, a role he took after leading the company's businesses first in the Middle East and then in South-East Asia, Novo said.
His most urgent challenge, according to investors and analysts, is to revive Novo's performance in the United States, the largest market by far for weight-loss drugs and where they are most profitable.
Novo launched its weight-loss drug Wegovy nearly two-and-a-half years before its US rival Eli Lilly's Zepbound.
Zepbound prescriptions surpassed those of Wegovy this year by more than 100,000 a week.
The appointment comes at a challenging time for the global pharmaceutical industry as US President Donald Trump threatens to impose tariffs on imports and calls on drug makers to lower their American prescription prices.
Mr Jorgensen led Novo through a period of meteoric growth as it led the weight-loss drug boom, becoming Europe's most valuable listed company after the launch of Wegovy in 2021.
At its peak in June 2024 Novo was worth as much as $US615 billion ($946.4b).
Novo shares have plunged over the past 12 months, amid investor concerns about the company's experimental drug pipeline and its ability to navigate challenges in the US market, such as the threat to its sales from compounded copies of Wegovy and Lilly's Zepbound.
On Tuesday, Novo cut its full-year sales and operating profit forecasts for the second time this year, sending its shares down as much as 17 per cent.
"The lowered sales outlook for 2025 is driven by lower growth expectations for the second half of 2025," the company said in a statement.
"This is related to lower growth expectations for Wegovy in the US obesity market, lower growth expectations for Ozempic in the US GLP-1 diabetes market, as well as lower-than-expected penetration for Wegovy in select IO (International Operations) markets."
Novo now expects 2025 sales growth of between eight and 14 per cent in local currencies, down from its previous forecast range of between 13 and 21 per cent.
It also lowered its operating profit growth estimate to between 10 and 16 per cent, down from 16 to 24 per cent previously.
Sales rose 18 per cent year-on-year in both the second quarter and the first half of the year, Novo said.
Its operating profit increased by 40 per cent in the April-June quarter and by 29 per cent in the first half, the company added.
Booming sales of Wegovy catapulted Novo to become Europe's most valuable listed company in 2024, peaking at about 615 billion euros ($1.09t), but the value has since fallen by more than half.
The company is scheduled to release full second-quarter earnings on August 6.
Reuters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News AU
21 hours ago
- Sky News AU
Australian government secures tariff reprieve from US amid speculation beef import decision helped smooth outcome
Sky News understands that high-level trade talks between Australia's Trade Minister and the US Secretary of Commerce, along with Australia last week lifting restrictions on US beef imports likely played an outcome on the United States deciding to maintain a 10 per cent tariff on Australian exports. The decision is being hailed as a significant trade win for the Albanese government, with many believing the move on US beef may have helped to avert a higher tariff rate being imposed. It is understood that Trade Minister Don Farrell spoke directly with US Trade Secretary Howard Lutnick on Friday, where Mr Lutnick acknowledged there had been pressure within the US administration to raise tariffs above the current 10 per cent and those pressures were ultimately resisted. It's not known whether the pair formally discussed the beef import decision, but the timing has raised speculation that Canberra's move to allow in American beef helped smooth over negotiations. The outcome puts Australia ahead of key competitors in the US market, with New Zealand exports currently facing a 15 per cent tariff and Brazil subject to a 50 per cent rate. The government is viewing the result as a diplomatic win that will help defuse criticism over Australia's recent trade posture, including claims that the lack of a meeting between Prime Minister Anthony Albanese and US President Donald Trump had weakened the bilateral relationship. It also takes some pressure off the ongoing debate over whether former Prime Minister Kevin Rudd should remain in his post as Australia's ambassador in Washington. Sources say Mr Lutnick signalled interest in building closer ties with Australia during the phone call, reportedly telling Mr Farrell he had never visited the country but hoped to do so. While the tariff relief applies across all Australian exports, agriculture remains a key area of interest, with beef being a major export and import point for both nations. The government is expected to continue emphasising the strength of its trade relationships, particularly in the face of growing global economic uncertainty.
Sky News AU
a day ago
- Sky News AU
‘Americans have the same issues': Australian EV market impacted by poor infrastructure
Drive Magazine Motor Expert Trent Nikolic says Australia should look to the American electric vehicle market, which has similar characteristics, such as spread-out cities and a population that generally drives longer distances. 'Those countries where an electric vehicle suits the driving that the majority of people do, it makes sense to own one,' Mr Nikolic told Sky News Australia. 'We should be looking more at markets like the United States, which are very spread out, people drive long distances. 'The Americans have the same issues with infrastructure that we do.'
Sky News AU
a day ago
- Sky News AU
Donald Trump unhappy with grim US jobs report
The US Bureau of Labor Statistics has delivered a report reflecting a significant downturn in the job market following recent tariffs. Job numbers from May and June were revised down drastically and American companies only added about 73,000 jobs in July. In response, President Donald Trump is calling for the head of the bureau to be fired.
